Published date: Tuesday, February 1, 2022
Your guide to the Waldenstrom’s macroglobulinaemia guidelines | 194 KB
The British Society for Haematology publishes guidelines for the diagnosis and management of Waldenstrom’s macroglobulinaemia (WM). Guidelines like these are developed to provide healthcare professionals with clear guidance on how to care for their patients. You can read the full guidelines here.
For people with WM, this means you can expect improved care, no matter where you are being treated in the UK. Here, we’ve summarised the latest guidelines and what it means for your care. We’ve linked to more resources and reading in the document, if you want to learn more about unfamiliar terms or treatments.
If you’re looking for support or more information, we’re here to help. You can contact us any time by emailing firstname.lastname@example.org, calling 0300 303 5870, or by joining one of our many forums or support groups.
This factsheet was written in collaboration with WM clinician experts and WM patients.
Review date: 01/02/2024